Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDPasithea Therapeutics Corp. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2024 | Q3 2024 | -$2.87 | $0 | |||
| 08/13/2024 | Q2 2024 | -$3.71 | $0 | |||
| 05/14/2024 | Q1 2024 | -$3.70 | $0 | |||
| 03/28/2024 | Q4 2023 | -$4.85 | $976,306 | |||
| 11/13/2023 | Q3 2023 | -$2.87 | $0 | |||
| 08/11/2023 | Q2 2023 | -$2.88 | $0 | |||
| 05/12/2023 | Q1 2023 | -$211.05 | $0 | |||
| 03/30/2023 | Q4 2022 | -$3.00 | $240,712 | |||
| 11/14/2022 | Q3 2022 | -$3.45 | $218,608 | |||
| 08/15/2022 | Q2 2022 | -$0.08 | $13,581 | |||
| 05/16/2022 | Q1 2022 | $0.00 | $13,658 | |||
| 03/30/2022 | Q4 2021 | $0.06 | $15,062 | |||
| 11/18/2021 | Q3 2021 | -$0.17 | $0 | |||
| 06/30/2021 | Q2 2021 | -$0.07 | $0 | |||
| 03/31/2021 | Q1 2021 | -$0.04 | $0 | |||
| 12/31/2020 | Q4 2020 | -$0.13 | $0 | |||
| 09/30/2020 | Q3 2020 | -$0.00 | $0 |
Pasithea Therapeutics Corp. Earnings: FAQ's
When is Pasithea Therapeutics Corp.'s earnings date?
Pasithea Therapeutics Corp. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 30th, 2023 based off last year's report dates.
How can I listen to Pasithea Therapeutics Corp.'s earnings conference
call?
The conference call for Pasithea Therapeutics Corp.'s latest earnings report can be listened to online.
How can I read Pasithea Therapeutics Corp.'s conference call transcript?
The conference call transcript for Pasithea Therapeutics Corp.'s latest earnings report can be read online.
How much profit does Pasithea Therapeutics Corp. generate each year?
Pasithea Therapeutics Corp. (:KTTAW) has a recorded net income of $0. Pasithea Therapeutics Corp. has generated $-12.65 earnings per share over the last four quarters.
What is Pasithea Therapeutics Corp.'s price-to-earnings ratio?
Pasithea Therapeutics Corp. (:KTTAW) has a price-to-earnings ratio of -0.21 and price/earnings-to-growth ratio is 0.